EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reduced expression of alanyl aminopeptidase is a robust biomarker of non‐familial adenomatous polyposis and non‐hereditary nonpolyposis colorectal cancer syndrome early‐onset colorectal cancer

Ye Jin Ha iD, Yun Jae Shin iD, Ka Hee Tak iD, Jong Lyul Park iD, Jeong Hwan Kim iD, Jong Lyul Lee iD, Yong Sik Yoon iD, Chan Wook Kim iD, Seon Young Kim iD, Jin Cheon Kim iD

Cancer Medicine · 2023

DOI: 10.1002/cam4.5675 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Ye Jin Ha und 9 weiteren Autor:innen. Beteiligte Einrichtung: Asan Institute for Life Sciences, Asan Medical Center, Seoul, South Korea. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Adenomatous Polyposis Coli, Colorectal Neoplasms, Hereditary Nonpolyposis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Early‐onset colorectal cancer (EOCRC) has been increasing in incidence worldwide but its genomic pathogenesis is mostly undetermined. This study aimed to identify robust EOCRC‐specific gene expression patterns in non‐familial adenomatous polyposis (FAP) and non‐hereditary nonpolyposis colorectal cancer syndrome (HNPCC) EOCRC.

Method

We first performed gene expression profiling analysis using RNA sequencing of discovery cohort comprised of 49 EOCRC (age 70) specimens. To obtain robust gene expression data from this analysis, we validated differentially expressed genes (DEGs) through TCGA cohort (EOCRC:59 samples, LOCRC:229 samples) and our validation cohort (EOCRC:72 samples, LOCRC:43 samples) using real‐time RT‐PCR. After the validation of DEGs, we validated the selected gene at protein levels using Western blotting. To identify whether genomic methylation regulates the expression of a particular gene, we selected methylation sites using The Cancer Genome Atlas (TCGA) datasets and validated them by pyrosequencing in our validation cohort.

Results

The EOCRC patients included in this study had significantly more prominent family history of cancer than the LOCRC patients (23 [46.9%] vs. 13 [26%], p = 0.050). Alanyl aminopeptidase (ANPEP) was significantly downregulated in the EOCRC tissues (FC = 1.78, p = 0.0007) and was also commonly downregulated in the TCGA cohort (FC = −1.08, p = 0.0021). Moreover, the ANPEP mRNA and protein expression levels were significantly downregulated in the EOCRC tissues of our validation cohort ( p = 0.037 and 0.027). In comparisons of the normal and tumor tissues in public datasets, the ANPEP level was significantly lower in the tumor tissue in the TCGA dataset ( p < 2.2 × 10 −16 ) and GSE196006 dataset ( p = 0.0005). Furthermore, the ANPEP expression level did not show a decreasing tendency at a young age in the normal colon tissue of the GTEx dataset. Lastly, the hypermethylation of cg26222247 in ANPEP was identified to be weakly associated with reduced ANPEP expression in our EOCRC cohort.

Conclusion

The reduced expression of ANPEP was identified as a novel biomarker of non‐FAP and non‐HNPCC EOCRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsAdenomatous Polyposis ColiColorectal Neoplasms, Hereditary NonpolyposisHumansCD13 AntigensBiomarkers

Stichwörter der Autor:innen

ANPEPbiomarkerearly-onset colorectal cancer (EOCRC)late-onset colorectal cancer (LOCRC)

Substanzen

CD13 AntigensBiomarkers

Autor:innen und Institutionen

  • Asan Institute for Life Sciences, Asan Medical Center, Seoul, South Korea.
  • Personalized Genomic Medicine Research Center, Daejeon, South Korea.
  • Korea Bioinformation Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, South Korea.
  • Department of Bioinformatics, University of Science and Technology (UST), Daejeon, South Korea.
  • Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

ORCID-Profile: Ye Jin Ha, Yun Jae Shin, Ka Hee Tak, Jong Lyul Park, Jeong Hwan Kim, Jong Lyul Lee, Yong Sik Yoon, Chan Wook Kim, Seon Young Kim, Jin Cheon Kim

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Ha, Y. J., Shin, Y. J., Tak, K. H., Park, J. L., Kim, J. H., Lee, J. L., Yoon, Y. S., Kim, C. W., Kim, S. Y., & Kim, J. C. (2023). Reduced expression of alanyl aminopeptidase is a robust biomarker of non‐familial adenomatous polyposis and non‐hereditary nonpolyposis colorectal cancer syndrome early‐onset colorectal cancer. Cancer Medicine. https://doi.org/10.1002/cam4.5675

Vancouver

Ha YJ, Shin YJ, Tak KH, Park JL, Kim JH, Lee JL, et al. Reduced expression of alanyl aminopeptidase is a robust biomarker of non‐familial adenomatous polyposis and non‐hereditary nonpolyposis colorectal cancer syndrome early‐onset colorectal cancer. Cancer Medicine. 2023. doi:10.1002/cam4.5675

BibTeX
@article{Ha2023,
  author = {Ha, Ye Jin and Shin, Yun Jae and Tak, Ka Hee and Park, Jong Lyul and Kim, Jeong Hwan and Lee, Jong Lyul and Yoon, Yong Sik and Kim, Chan Wook and Kim, Seon Young and Kim, Jin Cheon},
  title = {Reduced expression of alanyl aminopeptidase is a robust biomarker of non‐familial adenomatous polyposis and non‐hereditary nonpolyposis colorectal cancer syndrome early‐onset colorectal cancer},
  journal = {Cancer Medicine},
  year = {2023},
  doi = {10.1002/cam4.5675}
}
Kostenlos starten →